Blog

The “Team Spotlight” series will allow you to meet one of Wells Pharma’s highly experienced experts. This professional/personal look will help you get to know who we are, and give an inside look at how our team members work to achieve our goal of becoming a market leader in the…

The “Team Spotlight” series will allow you to meet one of Wells Pharma’s highly experienced experts. This professional/personal look will help you get to know who we are, and give an inside look at how our team members work to achieve our goal of becoming a market leader in the…

The “Team Spotlight” series will allow you to meet one of Wells Pharma’s highly experienced experts. This professional/personal look will help you get to know who we are, and give an inside look at how our team members work to achieve our goal of becoming a market-leader in the 503B…

5 Most Important Benefits Healthcare Providers receive by using a 503B Outsourcing Facility for Compounded Sterile Preparations (CSPs) Why would a hospital want to outsource CSPs? To answer this, one needs to understand how production has been handled in the past. Prior to 2013, hospitals and surgical centers either compounded…

The “Team Spotlight” series will allow you to meet one of Wells Pharma’s highly experienced experts. This professional/personal look will help you get to know who we are, and give an inside look at how our team members work to achieve our goal of becoming a market-leader in the 503B…

The “Team Spotlight” series will allow you to meet one of Wells Pharma’s highly experienced experts. This professional/personal look will help you get to know who we are, and give an inside look at how our team members work to achieve our goal of becoming a market leader in the…

As Wells Pharma approaches it’s one-year anniversary of commercial operations, I wanted to share a little about our future as an FDA-Registered 503B Outsourcing Facility.  First, we want to THANK our current and future customers who have supported our explosive growth!  I firmly believe that this is the direct result…

Wells Pharma produces commodity products, like all other players in the 503B industry.  A 5 mL syringe of 1mg/mL Neostigmine is exactly the same as that product from another outsourcer, and it is exactly the same as that product made in a hospital pharmacy.  There are no clinical advantages to…